-

WHO’s Actions Contradict “Zero Tolerance” Stance on Sexual Harassment and Abuse, says AHF

LOS ANGELES--(BUSINESS WIRE)--Following reports that the World Health Organization reinstated staffers accused of mishandling a sexual abuse scandal during an Ebola outbreak in the Democratic Republic of Congo – AIDS Healthcare Foundation condemns the decision to reappoint the employees as a sign the U.N. system is still struggling to handle sexual harassment and abuse allegations adequately.

“It is disappointing that no matter how many chances the WHO has had to correct past mistakes when addressing sexual misbehavior at the hands of its employees, it continues to make decisions that run counter to its commitment to ‘zero tolerance’ on sexual harassment and abuse,” said AHF Chief of Global Advocacy and Policy Terri Ford. “We and civil society more broadly disapprove of the pervasiveness and tacit acceptance of sexual misconduct within the WHO and the U.N. system. Those in charge must communicate unequivocally in their actions and words that sexual exploitation will not be tolerated in any form.”

AHF has advocated for justice for sex abuse victims and for decision-makers within the U.N. system to hold perpetrators accountable dating back to the scandal at UNAIDS and its then Executive Director Michel Sidibé, who later resigned before his term ended.

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation, the largest global AIDS organization, currently provides medical care and/or services to over 1.7 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1 323 308 1833 work, +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@aidshealth.org

AIDS Healthcare Foundation


Release Versions
Hashtags

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1 323 308 1833 work, +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@aidshealth.org

More News From AIDS Healthcare Foundation

AHF: Florida Lawmakers Reverse HIV Drug Cuts, Restoring Coverage for Thousands

TALLAHASSEE, Fla.--(BUSINESS WIRE)--Thousands of Floridians living with HIV will keep the medication that keeps them alive, after the Florida Legislature today passed a state budget that reverses this year's cuts to the AIDS Drug Assistance Program (ADAP). The budget returns eligibility to 400 percent of the federal poverty level, brings back the medications the Department of Health had dropped, including Biktarvy, funds the program with $75 million, and adds independent oversight. "This is wha...

AHF Calls for Access and Dignity on Menstrual Health Day

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) joins the global commemoration of Menstrual Health Day with events across nearly 50 countries, highlighting the importance of reducing period stigma and expanding access to affordable menstrual products—critical steps in protecting overall health and reducing vulnerability to HIV and other sexually transmitted infections. Menstrual Health Day is observed annually on May 28. Around the world, barriers to menstrual health continue to...

Ebola Crisis Exposes Failure of Current Global Health Architecture, says AHF

LOS ANGELES--(BUSINESS WIRE)--As Uganda and the Democratic Republic of the Congo (DRC) confront a rapidly evolving Ebola outbreak, AIDS Healthcare Foundation (AHF) warns that the crisis highlights persistent weaknesses in the world’s ability to respond quickly and equitably to emerging infectious disease threats. The current outbreak involves the Bundibugyo strain of Ebola virus, for which no approved vaccines or therapeutics currently exist, heightening concerns among global health officials a...
Back to Newsroom